367
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Relationship Between Liver Fibrosis and Increased Risk of Symptomatic Intracranial Hemorrhage in Ischemic Stroke Patients Undergoing Mechanical Thrombectomy

, ORCID Icon, , , , & show all
Pages 101-108 | Received 15 Nov 2023, Accepted 15 Jan 2024, Published online: 18 Jan 2024

References

  • Tu W, Zhao Z, Yin P, et al. Estimated Burden of Stroke in China in 2020. JAMA Network Open. 2023;6(3):e231455. doi:10.1001/jamanetworkopen.2023.1455
  • Arboix A, Oliveres M, Massons J, Pujades R, Garcia-Eroles L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol. 1999;6(6):677–683. doi:10.1046/j.1468-1331.1999.660677.x
  • Çinar T, Hayiroğlu Mİ, Selçuk M, et al. Evaluation of electrocardiographic P wave parameters in predicting long-term atrial fibrillation in patients with acute ischemic stroke. Arq Neuropsiquiatr. 2022;80(9):877–884. doi:10.1055/s-0042-1755322
  • Hayıroğlu Mİ, Çınar T, Selçuk M, et al. The significance of the morphology-voltage-P-wave duration (MVP) ECG score for prediction of in-hospital and long-term atrial fibrillation in ischemic stroke. J Electrocardiol. 2021;69:44–50. doi:10.1016/j.jelectrocard.2021.09.006
  • Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731. doi:10.1016/S0140-6736(16)00163-X
  • Zhang X, Xie Y, Wang H, et al. Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Chinese Ischemic Stroke Patients: the ASIAN Score. Stroke. 2020;51(9):2690–2696. doi:10.1161/STROKEAHA.120.030173
  • Zhang X, Yuan K, Wang H, et al. Nomogram to Predict Mortality of Endovascular Thrombectomy for Ischemic Stroke Despite Successful Recanalization. J Am Heart Assoc. 2020;9(3):e014899. doi:10.1161/JAHA.119.014899
  • Zhang X, Zhou F, Wang W, et al. Levels of adhesion molecules and clinical outcomes in patients with ischemic stroke after mechanical thrombectomy. Front Neurol. 2022;13:1024162. doi:10.3389/fneur.2022.1024162
  • Shah A, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104–1112. doi:10.1016/j.cgh.2009.05.033
  • Adams L, Anstee Q, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–1153. doi:10.1136/gutjnl-2017-313884
  • Heyens L, Busschots D, Koek G, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: from Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med Lausanne. 2021;8:615978. doi:10.3389/fmed.2021.615978
  • Chalasani N, Younossi Z, Lavine J, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357. doi:10.1002/hep.29367
  • Baik M, Nam H, Heo J, et al. Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack. Cerebrovasc Dis. 2020;49(5):474–480. doi:10.1159/000510436
  • Parikh N, Kamel H, Navi B, et al. Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage. Stroke. 2020;51(3):830–837. doi:10.1161/STROKEAHA.119.028161
  • Sucharew H, Khoury J, Moomaw C, et al. Profiles of the National Institutes of Health Stroke Scale items as a predictor of patient outcome. Stroke. 2013;44(8):2182–2187. doi:10.1161/STROKEAHA.113.001255
  • Barber P, Demchuk A, Zhang J, Buchan A. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670–1674. doi:10.1016/S0140-6736(00)02237-6
  • Adams HJ, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
  • Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650–2663. doi:10.1161/STROKEAHA.113.001972
  • Sterling R, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325. doi:10.1002/hep.21178
  • Fandler-Höfler S, Stauber R, Kneihsl M, et al. Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke. Ther Adv Neurol Disord. 2021;14:17562864211037239. doi:10.1177/17562864211037239
  • von Kummer R, Broderick JP, Campbell BC, et al. The Heidelberg Bleeding Classification: classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. Stroke. 2015;46(10):2981–2986. doi:10.1161/STROKEAHA.115.010049
  • Hao Y, Yang D, Wang H, et al. Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke. Stroke. 2017;48(5):1203–1209. doi:10.1161/STROKEAHA.116.016368
  • Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551–561. doi:10.1002/sim.4780080504
  • Norata D, Lattanzi S, Broggi S, Rocchi C, Bartolini M, Silvestrini M. Liver fibrosis-4 score predicts outcome of patients with ischemic stroke undergoing intravenous thrombolysis. Front Neurol. 2023;14:1103063. doi:10.3389/fneur.2023.1103063
  • du Plessis J, van Pelt J, Korf H, et al. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(3):635–48.e14. doi:10.1053/j.gastro.2015.05.044
  • Verrijken A, Francque S, Mertens I, et al. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2014;59(1):121–129. doi:10.1002/hep.26510
  • Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1. J Hepatol. 2020;72(1):156–166. doi:10.1016/j.jhep.2019.09.014
  • Weng S, Zhou J, Chen X, Sun Y, Mao Z, Chai K. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. Medicine. 2018;97(26):e11293. doi:10.1097/MD.0000000000011293
  • Beer S, Babel J, Martin N, Blank V, Wiegand J, Karlas T. Non-invasive assessment of steatohepatitis indicates increased risk of coronary artery disease. PLoS One. 2023;18(9):e0286882. doi:10.1371/journal.pone.0286882
  • Van Dyken P, Lacoste B. Impact of Metabolic Syndrome on Neuroinflammation and the Blood-Brain Barrier. Front Neurosci. 2018;12:930. doi:10.3389/fnins.2018.00930
  • Targher G, Day C, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341–1350. doi:10.1056/NEJMra0912063
  • Çinier G, Hayıroğlu Mİ, Kolak Z, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51(8):e13550. doi:10.1111/eci.13550
  • Speliotes E, Massaro J, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010;51(6):1979–1987. doi:10.1002/hep.23593
  • Nseir W, Shalata A, Marmor A, Assy N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011;56(12):3439–3449. doi:10.1007/s10620-011-1767-y
  • Duan W, Shi R, Yang F, et al. FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2023;22(1):297. doi:10.1186/s12933-023-02024-x
  • Zaidat O, Castonguay A, Gupta R, et al. North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results. J Neurointerv Surg. 2014;6(8):584–588. doi:10.1136/neurintsurg-2013-010895
  • van der Steen W, van der Ende NAM, van Kranendonk KR, et al. Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: a Retrospective Cohort Study. Stroke. 2022;53(9):2818–2827. doi:10.1161/STROKEAHA.121.036195
  • Venditti L, Chassin O, Ancelet C, et al. Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke. J Neurol. 2021;268(5):1867–1875. doi:10.1007/s00415-020-10364-x
  • Csecsei P, Tarkanyi G, Bosnyak E, et al. Risk analysis of post-procedural intracranial hemorrhage based on STAY ALIVE Acute Stroke Registry. J Stroke Cerebrovasc Dis. 2020;29(7):104851. doi:10.1016/j.jstrokecerebrovasdis.2020.104851